(Reuters) – The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
(Reporting by Pratik Jain in Bengaluru)
(Reuters) – The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
(Reporting by Pratik Jain in Bengaluru)
Comments